In order to achieve clinically relevant models of human prostate cancer in mice, several investigators have sought to generate bigenic knockout mice that combine PTEN haploinsufficiency with other genetic alterations to further characterize the role of PTEN in prostate tumorigenesis. The gene discussed is PTEN; the disease is prostate cancer.